AVALO THERAPEUTICS, INC. Cost of Goods Sold (Deprecated 2018-01-31)
AVALO THERAPEUTICS, INC. (AVTX) reported Cost of Goods Sold (Deprecated 2018-01-31) of $863.62 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-08-09
- AVALO THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $863.62K.
- AVALO THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $636.00K.
- AVALO THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00.
- AVALO THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $0.00.
- AVALO THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $635.65K.
- AVALO THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $0.00.
- AVALO THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $0.00.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 1 month | Cost of Goods Sold (Deprecated 2018-01-31) 1 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 4 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|---|
| 2018-03-31 | $100.00K 10-Q · filed 2018-08-09 | $16.20K 10-Q · filed 2018-05-11 | $863.62K 10-Q · filed 2018-05-11 | $29.25K 10-Q · filed 2018-05-11 | $1.50M derived: sum of 2 quarters · filed 2018-05-11 | $1.50M derived: sum of 3 quarters · filed 2018-05-11 | $1.50M derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-12-31 | $636.00K 10-K · filed 2018-04-02 | $636.00K derived: sum of 2 quarters · filed 2018-04-02 | $636.00K derived: sum of 3 quarters · filed 2018-04-02 | $635.65K 10-K · filed 2018-04-02 | |||
| 2017-09-30 | $0.00 10-K · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $0.00 derived: sum of 3 quarters · filed 2018-05-11 | ||||
| 2017-06-30 | $0.00 10-K · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-05-11 | |||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 | ||||||
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 | ||||||
| 2015-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |